Ivan M Robbins
Overview
Explore the profile of Ivan M Robbins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
4729
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
12.
Hemnes A, Luther J, Rhodes C, Burgess J, Carlson J, Fan R, et al.
JCI Insight
. 2019 Jan;
4(1).
PMID: 30626738
Background: Pulmonary arterial hypertension (PAH) is a deadly disease of the small pulmonary vasculature with an increased prevalence of insulin resistance (IR). Insulin regulates both glucose and lipid homeostasis. We...
13.
Hemnes A, Rathinasabapathy A, Austin E, Brittain E, Carrier E, Chen X, et al.
Eur Respir J
. 2018 Jun;
51(6).
PMID: 29903860
Pulmonary arterial hypertension (PAH) is a deadly disease with no cure. Alternate conversion of angiotensin II (AngII) to angiotensin-(1-7) (Ang-(1-7)) by angiotensin-converting enzyme 2 (ACE2) resulting in Mas receptor (Mas1)...
14.
Meoli D, Ru Su Y, Brittain E, Robbins I, Hemnes A, Monahan K
Pulm Circ
. 2017 Dec;
8(1):2045893217745019.
PMID: 29251543
Pulmonary hypertension complicating left heart disease (PH-LHD) is associated with increased morbidity and mortality, especially in patients who develop combined pre- and post-capillary PH (Cpc-PH). Mechanisms underlying PH-LHD are incompletely...
15.
Assad T, Maron B, Robbins I, Xu M, Huang S, Harrell F, et al.
JAMA Cardiol
. 2017 Oct;
2(12):1361-1368.
PMID: 29071338
Importance: Pulmonary hypertension (PH) is diagnosed by a mean pulmonary arterial pressure (mPAP) value of at least 25 mm Hg during right heart catheterization (RHC). While several studies have demonstrated...
16.
Welch C, Brittain E, Newman A, Robbins I, Pugh M, Newman J, et al.
Ann Am Thorac Soc
. 2017 Mar;
14(6):896-902.
PMID: 28345964
Rationale: Pulmonary arterial hypertension (PAH) is characterized in part by increased dead space ventilation, which can be estimated noninvasively at the bedside by measurement of end-tidal CO (ETco). Objectives: Prior...
17.
Assad T, Brittain E, Wells Q, Farber-Eger E, Halliday S, Doss L, et al.
Pulm Circ
. 2016 Sep;
6(3):313-21.
PMID: 27683608
Although commonly encountered, patients with combined postcapillary and precapillary pulmonary hypertension (Cpc-PH) have poorly understood pulmonary vascular properties. The product of pulmonary vascular resistance and compliance, resistance-compliance (RC) time, is...
18.
Robbins I, Pugh M, Hemnes A
Trends Cardiovasc Med
. 2016 Jun;
27(1):29-37.
PMID: 27345156
Chronic, unresolved thromboemboli are an important cause of pulmonary hypertension (PH) with specific treatment strategies differing from other types of PH. Chronic thromboembolic pulmonary hypertension (CTEPH) is classified as group...
19.
Matthews D, Le C, Robbins I, Petracek M, Pugh M, Brittain E, et al.
Pulm Circ
. 2016 Jun;
6(2):174-80.
PMID: 27252843
Predictors of functional outcomes in patients with chronic thromboembolic pulmonary hypertension (CTEPH) undergoing pulmonary thromboendarterectomy (PTE) are important to identify preoperatively. We hypothesized that baseline severity of pulmonary hypertension and...
20.
Hemnes A, Zhao M, West J, Newman J, Rich S, Archer S, et al.
Am J Respir Crit Care Med
. 2016 Mar;
194(4):464-75.
PMID: 26926454
Rationale: Idiopathic pulmonary arterial hypertension (IPAH) is usually without an identified genetic cause, despite clinical and molecular similarity to bone morphogenetic protein receptor type 2 mutation-associated heritable pulmonary arterial hypertension...